Aterian, Inc. (NASDAQ:ATER) Short Interest Down 76.0% in May

Aterian, Inc. (NASDAQ:ATER) was the target of a significant decline in short interest in May. As of May 15th, there was short interest totaling 465,657 shares, a decline of 76.0% from the April 30th total of 1,939,342 shares. Based on an average trading volume of 923,391 shares, the days-to-cover ratio is presently 0.5 days. Currently, 5.3% of the company’s stock are sold short.

Aterian Stock Down 4.3%

Shares of Aterian stock opened at $1.10 on Friday. The firm has a market cap of $11.90 million, a P/E ratio of -0.43 and a beta of 0.66. Aterian has a fifty-two week low of $0.52 and a fifty-two week high of $1.87. The business has a 50-day moving average price of $0.87 and a 200 day moving average price of $0.76.

Aterian (NASDAQ:ATER) last announced its quarterly earnings data on Friday, May 15th. The company reported ($0.39) earnings per share for the quarter, beating the consensus estimate of ($0.69) by $0.30. The firm had revenue of $0.02 million during the quarter, compared to analyst estimates of $15.82 million. Aterian had a negative return on equity of 82.05% and a negative net margin of 39.56%.

Institutional Trading of Aterian

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Goldman Sachs Group Inc. increased its holdings in Aterian by 73.0% in the first quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after buying an additional 9,026 shares during the last quarter. Citadel Advisors LLC increased its holdings in Aterian by 222.0% in the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock valued at $35,000 after buying an additional 22,865 shares during the last quarter. Susquehanna International Group LLP increased its holdings in Aterian by 310.2% in the third quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after buying an additional 30,637 shares during the last quarter. Finally, XTX Topco Ltd bought a new stake in Aterian in the second quarter valued at about $55,000. 7.02% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded Aterian from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, May 19th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Sell”.

Aterian Company Profile

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.